España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

andres pintaluba s.a. - amoxicilina trihidrato - premezcla medicamentosa - amoxicilina trihidrato 229,6 - amoxicilina - lechones destetados

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

beaphar b.v. - deltametrina - collar medicamentoso - deltametrina 0,77 - deltametrina - perros

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

beaphar b.v. - deltametrina - collar medicamentoso - deltametrina 1,04 - deltametrina - perros

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

beaphar b.v. - deltametrina - collar medicamentoso - deltametrina 1,04 - deltametrina - perros

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

beaphar b.v. - deltametrina - collar medicamentoso - deltametrina 0,77 - deltametrina - perros

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

beaphar b.v. - deltametrina - collar medicamentoso - deltametrina 1,04 - deltametrina - perros

Unión Europea - español - EMA (European Medicines Agency)

teva b.v. - ácido zoledrónico - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - medicamentos para el tratamiento de enfermedades óseas - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. el tratamiento de la enfermedad de paget de los huesos en adultos.

Unión Europea - español - EMA (European Medicines Agency)

bial portela & companhia s.a. - opicapone - mal de parkinson - medicamentos contra el parkinson - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Unión Europea - español - EMA (European Medicines Agency)

astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - enfermedad pulmonar, obstructiva crónica - medicamentos para la enfermedad obstructiva de las vías respiratorias enfermedades, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.

Unión Europea - español - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - medicamentos para el tratamiento de enfermedades óseas - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.